Please login to the form below
clinical
This page shows the latest clinical news and features for those working in and with pharma, biotech and healthcare.
Merck to acquire Pandion Therapeutics for $1.85bn
The investigational candidate completed a phase 1a clinical trial earlier this year, achieving its primary objective of safety and tolerability. ... In just a few years, we have taken that mission from idea to clinical proof of mechanism with PT101, our
Latest news
-
UPDATED: Regeneron’s COVID-19 antibody cocktail shows ‘clear efficacy’
In this trial, the IDMC found clear clinical efficacy on reducing the rate of hospitalisation and death with both doses of REGEN-COV (1, 200mg and 2, 400mg) tested in the
-
The five-step, rare disease-ready checklist
Monitor the competition. Create a clinical trial tracker that mines all relevant competitor data from clinicaltrials.gov and investor materials.
-
Protalix, Chiesi’s monthly treatment PRX-102 shows benefit in Fabry disease
The topline results from this study show that PRX-102, administered every four weeks by intravenous infusion, was well tolerated, with stable clinical presentation maintained in patients.
-
FDA briefing document backs J&J’s one-dose COVID-19 vaccine
J&J is seeking an EUA from the FDA based on phase 3 clinical trial data from the global ENSEMBLE study.
-
FDA updates guidance for COVID-19 vaccine makers addressing new variants
manufacturer. Apart from the manufacturing information, the FDA guidance recommends that clinical data for the effectiveness of modified vaccines should be supported by clinical immunogenicity studies. ... clinical studies.
More from news
Approximately 192 fully matching, plus 4,601 partially matching documents found.
Latest Intelligence
-
Integrating competitive intelligence into business development, licensing and M&A strategy
After hearing clinical and regulatory assessment of a critical competitive asset, it was concluded that we were misinterpreting the aggressiveness of a competitor in terms of its timelines for development. ... In the example case, a rigorous debate ensued
-
The promise of precision medicine
Currently, we do not have enough clinical geneticists, genetics counsellors or pharmacists who are versed in genomic data usage to integrate precision medicine fully into healthcare systems.
-
Working in true partnership in a time of change
Consider the people skills of each customer-facing team, their communication style and passion for specific areas, whether they are clinical, commercial or patient led, and their personal goals.
-
AI and accelerated computing ring in new era for healthcare
The typical drug discovery process takes about a decade, costs $2bn and suffers a 90% failure rate during clinical development. ... The clinical community is using federated learning approaches to build robust AI models across various institutions,
-
Rare genetic diseases – what’s in store for 2021?
In 2021 we can expect more clinical studies that produce meaningful data, more advanced research and an increase in drug approvals that offer truly innovative treatment options. ... It has taken 30 years for gene therapy to evolve from being just a
More from intelligence
Approximately 20 fully matching, plus 667 partially matching documents found.
Latest appointments
-
Sandra Carey takes on global president, expert audiences role at McCann Health
She has also been a practising pharmacist and practitioner for most of her career, working as a clinical pharmacist in a family practice setting, running diabetes and pain management clinics and
-
New hires at EMA, Gilead and BeiGene
In this role, Genovese will oversee the clinical development of Gilead’s investigational portfolio of treatments for inflammatory conditions. ... Raitt professor of medicine and clinical chief in the division of immunology and rheumatology.
-
Syneos Health appoints Tim Pantello as president of communications
Our entire model is about acceleration and our Communications organisation is built on agility and speed beyond big creative and standalone strategy, scale, clinical and scientific depth, skill and a ... Our ability to bring multiple disciplines together
-
Azafaros expands executive team with three senior hires
He joins from Helsinn Group, where he held the position of global head of clinical research and development. ... Prior to this, he held global clinical development and medical affairs leadership roles at Actelion Pharmaceuticals.
-
Ashfield appoints new global head of quality and compliance
Clinical. “Since joining Ashfield, Carey has transformed our Quality and Compliance department here in the US, creating a key differentiator for Ashfield and providing a valuable client service.
More from appointments
Approximately 3 fully matching, plus 525 partially matching documents found.
Latest from PMHub
-
4 ways to recruit Alzheimer’s disease patients for your clinical trial
So, follow these 4 tips, and you’ll be more likely to reach patients living with Alzheimer’s disease to engage with them about your clinical trial. ... This is important because if you have already built strong partnerships with a community, you can
-
![#DemandDiversity: Black history in clinical trials: It's more than just Tuskegee [Infographic]](http://www.pmlive.com/__data/assets/image/0019/1364032/varieties/w100.jpg "#DemandDiversity: Black history in clinical trials: It's more than just Tuskegee [Infographic]")
#DemandDiversity: Black history in clinical trials: It's more than just Tuskegee [Infographic]
Take a look at this infographic showing some of the most notorious clinical trials and medical research in history.
-
Rare Disease Day – why it’s important to show your stripes
But there is hope – an ever-growing number of pharmaceutical companies and biotechs are conducting clinical trials in rare diseases; furthermore, the role of PAGs is expanding, with an increasing focus ... then fundraise to support their clinical
-
#DemandDiversity: The science behind diversity
And that’s why it’s so important for us to improve diversity in clinical trials. ... Deep scepticism, concerns and uncertainty around the intentions of clinical trials exists in many communities.
-
5 reasons clinical trial drop-out rates are on the rise
They just plain forget! There are many, many aspects to a successful clinical trial. ... However, clinical trials are just one of many commitments in a patients’ life.
More from PMHub
Approximately 134 fully matching, plus 580 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
-
SENIOR MEDICAL WRITER
-
Salary TBC
- Senior Account Director - Med Comms Agency
-
Salary TBC
-
MEDICAL WRITER - HOME WORKING
-
Salary TBC
- ACCOUNT MANAGER / SENIOR ACCOUNT MANAGER
-
Salary TBC
- Sales Director, Healthcare communications agency, London/ SE UK
-
Six figure salary
- Bayer’s finerenone scores FDA priority review for chronic kidney disease
- First dose of Pfizer/BioNTech vaccine reduces COVID-19 infection risk by 70%
- Communique - Communiqué Awards
- GSK launches late-stage testing of RSV vaccine candidate in older adults
- AZ refutes reports suggesting its COVID-19 vaccine is less effective in the elderly
- FDA considers new safety warnings for Pfizer’s JAK inhibitor Xeljanz
- FDA authorises flexible storage for Pfizer/BioNTech COVID-19 vaccine
- UK introduces Rare Diseases Framework to improve the lives of people with rare diseases
- Protalix, Chiesi’s monthly treatment PRX-102 shows benefit in Fabry disease
- UPDATED: Regeneron’s COVID-19 antibody cocktail shows ‘clear efficacy’
- Merck to acquire Pandion Therapeutics for $1.85bn
- bluebird bio marks Rare Disease Day 2021 with launch of patient testimonial video
PMHub
Blue Latitude Health
Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...
Latest intelligence
- 4 ways to recruit Alzheimer’s disease patients for your clinical trial
- What key things do you need to remember to reach patients living with Alzheimer’s disease?...
- Integrating competitive intelligence into business development, licensing and M&A strategy
- The advantages of partnering with a competitive intelligence or knowledge management team...
- Reaching patients and HCPs during the pandemic
- COVID-19 has caused unprecedented disruption to drug launches, but some pharma companies avoided costly delays by quickly pivoting to digital channels...
Quick links
Infographics
